Press Release

POMPANO BEACH, Fla., May 29, 2024 (GLOBE NEWSWIRE) — BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacture, and commercialization of placental-derived biologics, will…

– Company Achieves Record-Breaking First Quarter Results for 2024, Marking the Launch of BioStem 2.0 –– Company Reports First Quarter EBITDA of $4.9 Million –– Project Continued Growth from Sales…